[Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex<sup>®</sup> for patients with premenopausal breast cancer].Xinyu Shao, Zefei Jiang, Zhaofeng Niu et al.|PubMed|2025Cited by 0